Sign in to view content

Randomized Trial of PRP vs Intravitreal Ranibizumab Plus Deferred PRP for Proliferative Diabetic Retinopathy

Andrew N. Antoszyk, MD FASRS

Video
Published 2016

Related

Suprachoroidal Delivery of RGX-314 for Diabetic Retinopathy Without CI-DME: Early Results From the Phase II ALTITUDE Study
Dennis M. Marcus, MD
Annual Meeting Talks
2021
Effect of 6 month anti-VEGF treatment for proliferative diabetic retinopathy on the quantitative metrics of the retinal microvasculature on OCTA
Quan V. Hoang, MD, PhD
On Demand Cases, Courses, and Papers
2019
Switching to Combination OPT-302 With Aflibercept From Prior Anti-VEGF-A Monotherapy in Eyes With Persistent Diabetic Macula Edema (DME)
David S. Boyer, MD
Annual Meeting Talks
2020

Category: Diabetic Retinopathy

See more